{"id":"0a893c53-f0eb-5ea0-aebc-346e3ca0f822","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-salicylate-blocks-nfkb","predicate":"inhibits","statement":"The anti-inflammatory drugs sodium salicylate and aspirin inhibited activation of nuclear factor kappa B, an inhibition which prevented degradation of the inhibitor I-kappa-B so that nuclear factor kappa B was retained in the cytosol, and both also inhibited nuclear factor kappa B-dependent transcription from the immunoglobulin kappa enhancer and the human immunodeficiency virus long terminal repeat in transfected T cells.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"264d473e-0128-5a78-acff-62c01e9e8ef6","mechanism_event_label":"Both compounds keep an inflammatory master switch locked out of the nucleus.","subject":{"id":"5739797a-3699-591b-95fd-f8b80e612713","slug":"salicylate","display_name":"Salicylate / salicylic acid","entity_type_key":"small_molecule"},"object":{"id":"e9837edf-0c70-5d80-a390-2dfe026d667d","slug":"nfkb-activation","display_name":"Activation of nuclear factor kappa B","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"264d473e-0128-5a78-acff-62c01e9e8ef6","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-salicylate-blocks-nfkb-event","event_type":"biochemical_relationship","label":"Both compounds keep an inflammatory master switch locked out of the nucleus.","description":"The anti-inflammatory drugs sodium salicylate and aspirin inhibited activation of nuclear factor kappa B, an inhibition which prevented degradation of the inhibitor I-kappa-B so that nuclear factor kappa B was retained in the cytosol, and both also inhibited nuclear factor kappa B-dependent transcription from the immunoglobulin kappa enhancer and the human immunodeficiency virus long terminal repeat in transfected T cells.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"role":"co_active_compound","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"4b7e6069-53d4-58cf-be3c-d63e362025bf","slug":"nfkbia","display_name":"Human I-kappa-B alpha / NFKBIA","entity_type_key":"protein"},"role":"stabilised_inhibitor","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"ecf9653e-8710-540d-953a-78ef96bf4752","slug":"rela","display_name":"Human NF-kappa-B p65 / RELA","entity_type_key":"protein"},"role":"retained_subunit","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"3a10a2b1-4cef-5786-ae3d-920e70a9fa12","slug":"ikba-degradation","display_name":"Phosphorylation and degradation of I-kappa-B-alpha","entity_type_key":"cellular_process"},"role":"blocked_process","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"5739797a-3699-591b-95fd-f8b80e612713","slug":"salicylate","display_name":"Salicylate / salicylic acid","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"e9837edf-0c70-5d80-a390-2dfe026d667d","slug":"nfkb-activation","display_name":"Activation of nuclear factor kappa B","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/aspirin-research/8052854.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"d1d488e1bc53706da4f733f3fecc2bb981c09c0aa2dccae2bac9fac1bb04cec1\", \"start_char\": 0, \"end_char\": 737, \"text_sha256\": \"d1d488e1bc53706da4f733f3fecc2bb981c09c0aa2dccae2bac9fac1bb04cec1\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Electrophoretic mobility shift and reporter transcription assays in transfected T cells","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Sodium salicylate and aspirin applied to nuclear factor kappa B activation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A cell-based mechanism recorded at the concentrations used in the assay, which are far above those reached by antiplatelet dosing. It does not distinguish the two compounds from one another.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.","comparator":null,"unit":null,"notes":"","entity":{"slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human cells","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Both compounds keep an inflammatory master switch locked out of the nucleus.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[asa-p8052854] Inhibition of NF-kappa B by sodium salicylate and aspirin. (1994). https://pubmed.ncbi.nlm.nih.gov/8052854/ DOI: 10.1126/science.8052854","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"T lymphocytes","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"1794588d-7236-50dc-a812-cb9da0a1641e","evidence_kind":"source_excerpt","locator":"Lines 468-479","start_line":468,"end_line":479,"excerpt":"### asa-salicylate-blocks-nfkb\nThe anti-inflammatory drugs sodium salicylate and aspirin inhibited activation of nuclear factor kappa B, an inhibition which prevented degradation of the inhibitor I-kappa-B so that nuclear factor kappa B was retained in the cytosol, and both also inhibited nuclear factor kappa B-dependent transcription from the immunoglobulin kappa enhancer and the human immunodeficiency virus long terminal repeat in transfected T cells.\nCondition category: normal\nnutrient_topic: Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.\nplain_language: Both compounds keep an inflammatory master switch locked out of the nucleus.\norganism: Human cells\ntissue_or_cell_type: T lymphocytes\nexperimental_model: Electrophoretic mobility shift and reporter transcription assays in transfected T cells\nlimitations: A cell-based mechanism recorded at the concentrations used in the assay, which are far above those reached by antiplatelet dosing. It does not distinguish the two compounds from one another.\nexposure: Sodium salicylate and aspirin applied to nuclear factor kappa B activation\nevidence_span: {\"source_cache\": \"artifacts/aspirin-research/8052854.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"d1d488e1bc53706da4f733f3fecc2bb981c09c0aa2dccae2bac9fac1bb04cec1\", \"start_char\": 0, \"end_char\": 737, \"text_sha256\": \"d1d488e1bc53706da4f733f3fecc2bb981c09c0aa2dccae2bac9fac1bb04cec1\"}\n[asa-p8052854] Inhibition of NF-kappa B by sodium salicylate and aspirin. (1994). https://pubmed.ncbi.nlm.nih.gov/8052854/ DOI: 10.1126/science.8052854","model_system":"Electrophoretic mobility shift and reporter transcription assays in transfected T cells","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [asa-p8052854] Inhibition of NF-kappa B by sodium salicylate and aspirin. (1994). https://pubmed.ncbi.nlm.nih.gov/8052854/ DOI: 10.1126/science.8052854","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"712cf519-cd27-5a8b-9e2f-961a98d7a27e","stable_key":"import-f8641d02-8413-5bd8-92e9-62ad49286e81","title":"Aspirin: the serine it acetylates, the enzyme that acetylation creates, the dose that separates platelet from vessel wall, and the metabolite that is a different drug (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"93dd4343051c131e40d4fc3c95a978cd65478c13dcdb3f2d42507c49b09cb647","revision_id":"694e8ee7-49ca-5e6c-b58b-8ba8f82c2ad8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}